Filing Details

Accession Number:
0001209191-14-051205
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-07 17:43:18
Reporting Period:
2014-08-07
Filing Date:
2014-08-07
Accepted Time:
2014-08-07 17:43:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1559053 Prothena Corp Plc PRTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1232119 W Arthur Homan C/O Prothena Biosciences Inc
650 Gateway Boulevard
South San Francisco CA 94080
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.01 Per Share Acquisiton 2014-08-07 2,000 $19.12 2,000 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Footnotes
  1. The shares were purchased in multiple trades at prices ranging from $19.06 to $19.25 inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  2. The shares are held by the Homan Family Trust, dated 9/21/2001, of which the Reporting Person is a trustee.